Lu Jiao

494 total citations
11 papers, 391 citations indexed

About

Lu Jiao is a scholar working on Molecular Biology, Pharmacology and Social Psychology. According to data from OpenAlex, Lu Jiao has authored 11 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 1 paper in Pharmacology and 1 paper in Social Psychology. Recurrent topics in Lu Jiao's work include RNA and protein synthesis mechanisms (4 papers), Cancer therapeutics and mechanisms (2 papers) and RNA modifications and cancer (2 papers). Lu Jiao is often cited by papers focused on RNA and protein synthesis mechanisms (4 papers), Cancer therapeutics and mechanisms (2 papers) and RNA modifications and cancer (2 papers). Lu Jiao collaborates with scholars based in United States, China and United Kingdom. Lu Jiao's co-authors include Tadao Funato, Mohammed Kashani–Sabet, Kevin J. Scanlon, T Tone, John J. Rossi, Toshiya Shitara, José Moreno, Anna M. Wu, Mohammed Kashani‐Sabet and Lawrence C. Sowers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of the New York Academy of Sciences and Biochemical Pharmacology.

In The Last Decade

Lu Jiao

11 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu Jiao United States	8	316	91	55	53	26	11	391
Maria Frangou‐Lazaridis Greece	14	280 0.9×	79 0.9×	28 0.5×	30 0.6×	13 0.5×	19	381
Asomi Sato Japan	11	248 0.8×	80 0.9×	88 1.6×	60 1.1×	9 0.3×	15	511
Linda S. Ulsh United States	7	304 1.0×	134 1.5×	67 1.2×	35 0.7×	12 0.5×	7	386
Sheikh M. Ismail United States	7	389 1.2×	87 1.0×	60 1.1×	66 1.2×	10 0.4×	13	500
Matthew Holmes United States	8	304 1.0×	76 0.8×	86 1.6×	14 0.3×	11 0.4×	11	407
Tom Ryder United States	4	255 0.8×	66 0.7×	79 1.4×	21 0.4×	4 0.2×	6	336
Zvezdan Pavlovic Canada	5	293 0.9×	83 0.9×	37 0.7×	18 0.3×	5 0.2×	5	374
Steven Thibodeau United States	6	168 0.5×	88 1.0×	26 0.5×	39 0.7×	10 0.4×	8	329
Diane E. Ingolia United States	12	369 1.2×	78 0.9×	218 4.0×	16 0.3×	17 0.7×	14	500
Margaret Grimaldi United Kingdom	10	471 1.5×	180 2.0×	61 1.1×	7 0.1×	38 1.5×	13	554

Countries citing papers authored by Lu Jiao

Since Specialization

Citations

This map shows the geographic impact of Lu Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Jiao more than expected).

Fields of papers citing papers by Lu Jiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Jiao. The network helps show where Lu Jiao may publish in the future.

Co-authorship network of co-authors of Lu Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Jiao. A scholar is included among the top collaborators of Lu Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Jiao. Lu Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Xiong, Ying, Wei Hong, Chong Chen, et al.. (2022). Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome. Molecular Medicine Reports. 26(6). 10 indexed citations

Zeng, Li, Hong Wei, Jingjing Hu, et al.. (2018). Identification of gene-specific DNA methylation signature for Colorectal Cancer. Cancer Genetics. 228-229. 5–11. 8 indexed citations

Zeng, Li, et al.. (2018). Signature consist of nine differentially methylated gene pairs to predict the prognosis for stage II colorectal cancer patients. Oncotarget. 0(0). 1 indexed citations

Jiao, Lu, et al.. (2001). [Clinical observation of music therapy combined with anti-tumor drugs in treating 116 cases of tumor patients].. PubMed. 21(12). 891–4. 9 indexed citations

Ohta, Y., Toshiya Shitara, Tadao Funato, et al.. (1994). H‐ras Ribozyme‐Mediated, Alteration of the Human Melanoma Phenotypea. Annals of the New York Academy of Sciences. 716(1). 242–256. 23 indexed citations

Funato, Tadao, et al.. (1994). Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme. Biochemical Pharmacology. 48(7). 1471–1475. 26 indexed citations

Funato, Tadao, et al.. (1992). The utility of an antifos ribozyme in reversing cisplatin resistance in human carcinomas. Advances in Enzyme Regulation. 32. 195–209. 43 indexed citations

Kashani–Sabet, Mohammed, Tadao Funato, T Tone, et al.. (1992). Reversal of the Malignant Phenotype by an Anti- ras Ribozyme. PubMed. 2(1). 3–15. 92 indexed citations

Miyachi, Hayato, Lu Jiao, Lawrence C. Sowers, & Kevin J. Scanlon. (1992). Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.. PubMed. 6(1). 17–21. 6 indexed citations

10.

Scanlon, Kevin J., Lu Jiao, Tadao Funato, et al.. (1991). Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.. Proceedings of the National Academy of Sciences. 88(23). 10591–10595. 171 indexed citations

11.

Jiao, Lu, et al.. (1990). Effects of S86019, an active component fromPuralia lobata, on cell differentiation and cell cycle traverse of HL-60 cells. Chinese Journal of Cancer Research. 2(3). 51–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact